MX337194B - Preparados, metodos y estuches utiles para el tratamiento de la tos. - Google Patents

Preparados, metodos y estuches utiles para el tratamiento de la tos.

Info

Publication number
MX337194B
MX337194B MX2010005643A MX2010005643A MX337194B MX 337194 B MX337194 B MX 337194B MX 2010005643 A MX2010005643 A MX 2010005643A MX 2010005643 A MX2010005643 A MX 2010005643A MX 337194 B MX337194 B MX 337194B
Authority
MX
Mexico
Prior art keywords
cough
preparations
treatment
methods
kits useful
Prior art date
Application number
MX2010005643A
Other languages
English (en)
Other versions
MX2010005643A (es
Inventor
Jeffrey Alan Sargent
Stephen Andras Kovacs
Helen Rochelle Kemp
Kristin Rhedrick Williams
Mary Lynn Jump
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2010005643A publication Critical patent/MX2010005643A/es
Publication of MX337194B publication Critical patent/MX337194B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a un preparado, para las vías respiratorias que suministra alivio para la tos en un humano; el preparado comprende: un agente formador de película; un agente espesante; y el preparado para las vías respiratorias suministra alivio inmediato. Además, la invención se refiere a un método para suministrar alivio para la tos en un humano; el método comprende: los pasos de administrar a un humano un preparado para las vías respiratorias; el preparado comprende: un agente formador de película; un agente espesante; y en donde el preparado para las vías respiratorias suministra alivio para la tos inmediato según se necesite.
MX2010005643A 2007-11-21 2008-11-20 Preparados, metodos y estuches utiles para el tratamiento de la tos. MX337194B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US388607P 2007-11-21 2007-11-21
US2854708P 2008-02-14 2008-02-14
PCT/US2008/084201 WO2009067605A2 (en) 2007-11-21 2008-11-20 Preparations, methods and kits useful for treatment of cough

Publications (2)

Publication Number Publication Date
MX2010005643A MX2010005643A (es) 2010-07-30
MX337194B true MX337194B (es) 2016-02-15

Family

ID=40303655

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010005643A MX337194B (es) 2007-11-21 2008-11-20 Preparados, metodos y estuches utiles para el tratamiento de la tos.
MX2010005642A MX2010005642A (es) 2007-11-21 2008-11-20 Preparados, metodos y estuches para el tratamiento de la tos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2010005642A MX2010005642A (es) 2007-11-21 2008-11-20 Preparados, metodos y estuches para el tratamiento de la tos.

Country Status (11)

Country Link
US (3) US20090155189A1 (es)
EP (2) EP2219677A1 (es)
JP (1) JP2011504184A (es)
CN (2) CN101868253A (es)
AU (1) AU2008326386B2 (es)
BR (2) BRPI0819819A2 (es)
CA (2) CA2706472A1 (es)
ES (1) ES2655477T3 (es)
MX (2) MX337194B (es)
RU (1) RU2476240C2 (es)
WO (2) WO2009066262A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011005032A (es) * 2008-11-13 2011-06-16 Vdf Futureceuticals Inc Composiciones y metodos para aliviar hiposalivacion y para proveer confort oral.
CA2649936A1 (en) * 2009-01-15 2010-07-15 John Lawrence Rowe Honey product having a low water content
US20110104080A1 (en) 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
US20110104081A1 (en) 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
US20110195042A1 (en) * 2010-02-10 2011-08-11 Thomas Edward Huetter Compositions, Methods and Kits Useful for Treating a Respiratory Symptom
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US9987224B2 (en) * 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
US8992893B2 (en) 2011-04-19 2015-03-31 Arms Pharmaceutical, Llc Method of inhibiting harmful microorganisms and barrier-forming composition therefor
KR101915056B1 (ko) * 2012-04-10 2018-11-07 한미약품 주식회사 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions
DE102013000699A1 (de) * 2012-10-04 2014-04-10 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung, insbesondere pharmazeutische Zusammensetzung, insbesondere zur Verabreichung bei Heiserkeit
LT2908831T (lt) * 2012-10-17 2018-03-26 Montero Gida Sanayi Ve Ticaret A.S. Žoliniai preparatai
EA201590572A1 (ru) * 2012-10-17 2015-09-30 Монтеро Гида Санайи Ве Тиджарет А.С. Новые составы, содержащие экстракты растений
JP6901824B2 (ja) * 2013-01-04 2021-07-14 アームズ ファーマシューティカル エルエルシーＡｒｍｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｌｌｃ． 微生物により引き起こされる若しくは悪化する疾患の治療方法、又はその症状の緩和方法
WO2014127118A1 (en) 2013-02-13 2014-08-21 The Procter & Gamble Company Anise flavored medication
US20140294990A1 (en) * 2013-03-27 2014-10-02 Timothy P. O'Connor Throat gargle tablet and method of use thereof
CN103432029B (zh) * 2013-08-15 2016-02-17 金红叶纸业集团有限公司 组合物及应用其的纸巾
ITRM20130592A1 (it) * 2013-10-25 2015-04-26 Aboca Spa Societa Agricola Composizione per la tosse.
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
CN103875802B (zh) * 2014-04-15 2015-04-08 厦门绿链集成服务有限公司 一种新鲜水果的保鲜方法
CN107028987A (zh) * 2017-04-11 2017-08-11 成都吉氧屋科技有限公司 一种微生物黏附率调节剂及其应用
US11007171B2 (en) * 2017-07-13 2021-05-18 Summit Innovation Labs, LLC Treatment and prevention of joint disorders
FR3074688B1 (fr) 2017-12-13 2020-07-10 Roquette Freres Systeme epaississant et stabilisant d'origine naturelle convenant notamment a la preparation de produits cosmetiques
US11273123B2 (en) 2018-07-18 2022-03-15 USpharma Ltd Chewable pharmaceutical dosage forms
US20220047627A1 (en) * 2018-10-22 2022-02-17 Cmpd Licensing, Llc Non-infective nasal symptom management compositions and methods
US20220062173A1 (en) * 2019-01-08 2022-03-03 Johnson & Johnson Consumer Inc. Liquid compositions
CN112439072A (zh) * 2019-08-29 2021-03-05 鲁南制药集团股份有限公司 一种掩味组合物及其制备方法、用途
CN116726054B (zh) * 2022-12-05 2024-03-26 山东新时代药业有限公司 一种即食型益生菌组合物及其制备方法、用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1121358A (en) * 1965-10-21 1968-07-24 Bristol Myers Co Aerosol manufacture
US4029797A (en) * 1973-06-20 1977-06-14 Fisons Corporation Process of making cough syrup with masked noscapine
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
ES2033464T3 (es) 1987-09-04 1993-03-16 The Procter & Gamble Company Composiciones de relleno que contienen psyllium.
DK0387933T3 (da) 1989-03-16 1993-12-06 Procter & Gamble Psylliumholdige, bagte småkagesammensætninger
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
US5296209A (en) 1992-01-17 1994-03-22 Colgate Palmolive Company Pet chew product having oral care properties
CA2121435C (en) * 1993-04-16 2002-01-22 Sheila M. Ratnaraj Aqueous pharmaceutical suspension and process for preparation thereof
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
WO1996021432A1 (en) * 1995-01-11 1996-07-18 Cygnus, Inc. Delivery of active substances by way of mucosal surfaces of pharyngeal and esophageal regions
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
CA2222407A1 (en) * 1995-06-05 1996-12-12 Ira D. Hill Oral care ultramulsion based products
FR2741535B1 (fr) * 1995-11-28 1998-12-24 Sun Trading Ltd Nouvelles preparations pour la sphere bucco-pharyngee
FR2757022B1 (fr) * 1996-12-13 1999-03-05 Bel Fromageries Nouveau procede d'enrobage pour produits alimentaires et les produits enrobes obtenus
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
US6599883B1 (en) * 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
GB9827355D0 (en) * 1998-12-11 1999-02-03 Biochemie Sa Organic compounds
IN186667B (es) 1999-01-29 2001-10-20 Ajanta Pharma Ltd
US6230052B1 (en) * 1999-01-29 2001-05-08 Andy Wolff Device and method for stimulating salivation
SK15692002A3 (sk) * 2000-04-28 2003-11-04 Inflazyme Pharmaceuticals Limited 3-Amino-6,7-dioxygénované steroidy a s nimi súvisiace použitie
US6721999B2 (en) * 2001-04-30 2004-04-20 Absolute Closure Innovations, Inc. Device for creating a seal between fabrics or other materials
US6696047B2 (en) * 2001-09-13 2004-02-24 The Procter & Gamble Company Stable oral care compositions comprising chlorite
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
US20030170371A1 (en) 2002-01-10 2003-09-11 Cargill, Inc. High fat/fiber composition
US20060193959A1 (en) 2002-10-30 2006-08-31 Li Nie Low calorie injection molded starch-based pet chew bodies
US20050214349A1 (en) 2002-10-30 2005-09-29 Li Nie Extruded gluten based pet chew bodies
DE10253331A1 (de) * 2002-11-14 2004-06-03 Symrise Gmbh & Co. Kg Verwendung von trans-Pellitori als Aromastoff
CA2505833A1 (en) * 2002-11-14 2004-06-03 Innozen, Inc. Edible film for relief of cough or symptoms associated with pharyngitis
DE10261061A1 (de) 2002-12-24 2004-07-15 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
ES2342935T3 (es) 2003-01-13 2010-07-19 THE PROCTER & GAMBLE COMPANY Composiciones para prevencion y tratamiento de sintomas de tipo resfriado y gripe que comprenden polimeros mucoadhesivos seleccionados.
WO2004084637A1 (en) 2003-03-24 2004-10-07 Council Of Scientific And Industrial Research A high fibre biscuit composition and a process for preparing the same
RU2342853C2 (ru) * 2003-06-05 2009-01-10 Кооперати Авебе У. А. Быстродиспергируемые, предварительно желатинизированные крахмалы для использования в пищевых продуктах
US7118772B2 (en) 2003-09-18 2006-10-10 General Mills, Inc. Inulin infused fruit and method of preparation
WO2005046347A2 (en) 2003-11-07 2005-05-26 Mgp Ingredients, Inc. Composition and method for making high-protein and low-carbohydrate food products
US20060039973A1 (en) 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including water soluble dietary fiber
US20060120967A1 (en) * 2004-12-07 2006-06-08 Qpharma, Llc Solution forms of cyclodextrins for nasal or throat delivery of essential oils
US20060188450A1 (en) * 2005-02-24 2006-08-24 Tim Clarot System and method for suppressing a cough
US20070042023A1 (en) * 2005-08-22 2007-02-22 National Starch And Chemical Investment Holding Corporation Dissolvable film
US20070048424A1 (en) * 2005-09-01 2007-03-01 Moza Ashok K Liquid composition of 2-Isopropyl-N,2,3-trimethylbutyramide and N-Ethyl-p-menthane-3-carboxamide, its preparation method and its applications as a cooling agent and flavor enhancer
JP5203965B2 (ja) * 2005-12-23 2013-06-05 クラフト・フーズ・グローバル・ブランズ・エルエルシー メントールと同様の感覚をもたらす組成物
EP2001448A2 (en) 2006-01-27 2008-12-17 Cadbury Adams USA LLC Flavor-enhancing compositions, methods of manufacture, and methods of use
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine

Also Published As

Publication number Publication date
WO2009066262A1 (en) 2009-05-28
CN101868252A (zh) 2010-10-20
CA2706472A1 (en) 2009-05-28
JP2011504184A (ja) 2011-02-03
AU2008326386A1 (en) 2009-05-28
CN101868253A (zh) 2010-10-20
EP2217279A2 (en) 2010-08-18
EP2217279B1 (en) 2017-11-01
RU2010116996A (ru) 2011-12-27
CA2706440C (en) 2014-03-25
BRPI0819338A2 (pt) 2015-05-19
CA2706440A1 (en) 2009-05-28
RU2476240C2 (ru) 2013-02-27
WO2009067605A2 (en) 2009-05-28
US20090155189A1 (en) 2009-06-18
ES2655477T3 (es) 2018-02-20
BRPI0819819A2 (pt) 2015-05-26
US9149429B2 (en) 2015-10-06
MX2010005643A (es) 2010-07-30
US20090130199A1 (en) 2009-05-21
MX2010005642A (es) 2010-07-30
WO2009067605A3 (en) 2010-02-11
AU2008326386B2 (en) 2014-07-31
EP2219677A1 (en) 2010-08-25
US20160000925A1 (en) 2016-01-07

Similar Documents

Publication Publication Date Title
MX2010005643A (es) Preparados, metodos y estuches utiles para el tratamiento de la tos.
MX2010008720A (es) Composiciones, metodos y estuches para mejorar la respuesta inmunitaria a una enfermedad respiratoria.
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
WO2007142752A3 (en) Polymer-bioceramic composite implantable medical devices
SG173683A1 (en) Methods and systems for diagnosis and treatment of a defined condition, and methods for operating such systems
WO2008036206A3 (en) Copolymer-bioceramic composite implantable medical devices
MX2009007254A (es) Composiciones de tableta en tableta.
TW200716646A (en) (S)-N-methylnaltrexone
AU2016219650A1 (en) Compositions and methods for extended therapy with aminopyridines
WO2010025321A3 (en) Method for treating multiple sclerosis patients with anti-il2r antibodies
GB0611606D0 (en) Protection against and treatment of age related macular degeneration
SG10201408374WA (en) Therapeutic Combinations Of Theobromine And An Antihistamine
EP2029615B8 (en) A process for the preparation of an oxaliplatin
IL194353A0 (en) Lysobactin amides
MX343222B (es) Combinacion de teobrina con un descongestionante y su uso para el tratamiento de la tos.
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease
WO2011050099A3 (en) Therapeutic composition
WO2009134396A3 (en) Use of corticotropin-releasing factor for the treatment of cancer
IL191690A0 (en) Therapy of malignant neoplasias
WO2010043769A3 (en) Use of betaine
WO2012057417A8 (ko) 홍어 추출물을 함유하는 조성물
UA11545U (uk) Спосіб корекції порушення обмінно-імунних процесів у комплексній терапії хворих на псоріатичну хворобу
UA56675U (ru) Способ местного лечения генерализованного пародонтита c использованием синглетно-кислородной терапии
UA48591U (ru) Способ лечения разлитых флегмон челюстно-лицевого участка

Legal Events

Date Code Title Description
FG Grant or registration